Z Squared (ZSQR) Cash & Equivalents (2019 - 2026)
Z Squared (ZSQR) reported Cash & Equivalents of $15.49 million for Q2 2026, up 197.3% from the prior quarter.
Powered by 
Analysis
Z Squared (ZSQR) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Z Squared posted Cash & Equivalents of $1,402.
- Cash & Equivalents has a five-year compound annual growth rate of -63.0% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $1.47 million in FY2023 (-61.2%), $3.79 million in FY2022 (+73.9%) and $2.18 million in FY2021 (+973.9%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents in data going back to Q4 2019.
- Year over year, Cash & Equivalents gained in three of the last four quarters, with growth averaging 162.2%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2021 (growth of 973.9%); the low point was Q3 2023 (a decline of 80.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.21 million (Q1 2026), $1,402 (Q4 2025) and $4.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Z Squared | 121.90 Mn | 95.14 Mn | -1.77 Mn | 15.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.49 Mn |
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 1,402.00 |
| Sep 30, 2025 | 4.91 Mn |
| Mar 31, 2025 | 4.27 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 7.37 Mn |
| Jun 30, 2022 | 2.38 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 2.18 Mn |
| Sep 30, 2021 | 584,634.00 |
| Jun 30, 2021 | 644,481.00 |
| Mar 31, 2021 | 766,686.00 |
API Access
Z Squared Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZSQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ZSQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZSQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();